Imperial College of Science, Technology and Medicine operating as Imperial College London

29 capabilities Verified Sep 2026 One of 2,380 in United Kingdom

Send Enquiry

Send one structured enquiry and we chase the reply for you. No cold email, no chasing.

Details

Molecular Diagnostics Unit, Room I.2.3, 2nd Floor, Lift Bank D, Chelsea & Westminster Hospital, 369 Fulham Road
London SW10 9NH , United Kingdom

Accreditation

Active UKAS 9003

+44 (0)20 7594 3917

imperial.ac.uk Prefer to enquire through us? Send an enquiry

Accreditation Details

Accreditation Body

UKAS

Number

9003

Status

Active

Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.

Download Scope PDF

Test Capabilities (29)

Send an Enquiry

Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.

Your name *

Your email *

Company *

Test method / standard Please select a test method from the list

Material / sample type

Number of samples / specimens

Timeline

Volume

Additional details (optional)

Imperial College of Science, Technology and Medicine operating as Imperial College London

United Kingdom Accreditation Service № 9003

Direct & private Your message goes straight to the lab

No obligation Free to enquire, no commitment required

What happens next?

We send your enquiry to the lab
The lab will review your enquiry and reply directly to your email
You agree on testing scope, timeline, and pricing

Report incorrect or outdated information

Standard Reference	Description	Category
HCV direct acting agents. \| MDU0314 MiSeq Sample Library	HCV direct acting agents. \| MDU0314 MiSeq Sample Library	Molecular Diagnostics / PCR
HCV direct acting agents. \| MDU1002 HCV NS5b Resistance	HCV direct acting agents. \| MDU1002 HCV NS5b Resistance	Molecular Diagnostics / PCR
HCV direct acting agents. \| MDU1004 HCV NS5a Resistance	HCV direct acting agents. \| MDU1004 HCV NS5a Resistance	Molecular Diagnostics / PCR
HCV direct acting agents. \| Reporting SOP MDU 1003	HCV direct acting agents. \| Reporting SOP MDU 1003	Molecular Diagnostics / PCR
HCV direct acting agents. \| SOP MDU0312 Operation of the	HCV direct acting agents. \| SOP MDU0312 Operation of the	Molecular Diagnostics / PCR
HCV direct acting agents. \| SOP MDU0316 Operation of the	HCV direct acting agents. \| SOP MDU0316 Operation of the	Molecular Diagnostics / PCR
HCV direct acting agents. \| SOP MDU1001 HCV NS3	HCV direct acting agents. \| SOP MDU1001 HCV NS3	Molecular Diagnostics / PCR
HIV-1 associated with reduced \| MDU0314	HIV-1 associated with reduced \| MDU0314	Molecular Diagnostics / PCR
HIV-1 associated with reduced \| MiSeq Sample Library Preparation	HIV-1 associated with reduced \| MiSeq Sample Library Preparation	Molecular Diagnostics / PCR
HIV-1 associated with reduced \| Next Generation	HIV-1 associated with reduced \| Next Generation	Molecular Diagnostics / PCR
HIV-1 associated with reduced \| Next Generation Sequencer	HIV-1 associated with reduced \| Next Generation Sequencer	Molecular Diagnostics / PCR
HIV-1 associated with reduced \| Next Generation Sequencing	HIV-1 associated with reduced \| Next Generation Sequencing	Molecular Diagnostics / PCR
HIV-1 associated with reduced \| Operation of the Illumina MiSeq	HIV-1 associated with reduced \| Operation of the Illumina MiSeq	Molecular Diagnostics / PCR
HIV-1 associated with reduced \| Operation of the Illumina iSeq	HIV-1 associated with reduced \| Operation of the Illumina iSeq	Molecular Diagnostics / PCR
HIV-1 associated with reduced \| Reporting SOP MDU 0302	HIV-1 associated with reduced \| Reporting SOP MDU 0302	Molecular Diagnostics / PCR
HIV-1 associated with reduced \| Reporting and storage of HIV-1	HIV-1 associated with reduced \| Reporting and storage of HIV-1	Molecular Diagnostics / PCR
HIV-1 associated with reduced \| SOP MDU0311	HIV-1 associated with reduced \| SOP MDU0311	Molecular Diagnostics / PCR
HIV-1 associated with reduced \| SOP MDU0312	HIV-1 associated with reduced \| SOP MDU0312	Molecular Diagnostics / PCR
HIV-1 associated with reduced \| SOP MDU0316	HIV-1 associated with reduced \| SOP MDU0316	Molecular Diagnostics / PCR
HTLV 1&2 proviral detection and \| Imperial College of Science, Technology and Medicine	HTLV 1&2 proviral detection and \| Imperial College of Science, Technology and Medicine	Molecular Diagnostics / PCR
HTLV 1&2 proviral detection and \| Nsted PCR with gel	HTLV 1&2 proviral detection and \| Nsted PCR with gel	Molecular Diagnostics / PCR
HTLV 1&2 proviral detection and \| SureCycler 8800	HTLV 1&2 proviral detection and \| SureCycler 8800	Molecular Diagnostics / PCR
Whole blood (EDTA) and CSF HTLV 1 & 2 proviral load \| Manual extraction, real-time	Whole blood (EDTA) and CSF HTLV 1 & 2 proviral load \| Manual extraction, real-time	Molecular Diagnostics / PCR
Whole blood (EDTA) and CSF HTLV 1 & 2 proviral load \| QPCR using BioRad CFX	Whole blood (EDTA) and CSF HTLV 1 & 2 proviral load \| QPCR using BioRad CFX	Molecular Diagnostics / PCR
Whole blood (EDTA) and CSF HTLV 1 & 2 proviral load \| SOP MDU0400 In-house method	Whole blood (EDTA) and CSF HTLV 1 & 2 proviral load \| SOP MDU0400 In-house method	Molecular Diagnostics / PCR
HIV-1 associated with reduced \| Imperial College of Science, Technology and Medicine	HIV-1 associated with reduced \| Imperial College of Science, Technology and Medicine	Other
HIV-1 associated with reduced \| In-house PCR amplification and	HIV-1 associated with reduced \| In-house PCR amplification and	Other
HTLV 1&2 proviral detection and \| ABI GeneAmp 9700 and	HTLV 1&2 proviral detection and \| ABI GeneAmp 9700 and	Other
diagnosis \| Procedures documented in	diagnosis \| Procedures documented in	Other